Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New feature:   Automatically detect candlestick patterns on any chart

Read How
Market News Market Pulse Stocks News ETF News Crypto News

Korro Bio, Inc.

Contributing Author

Recent Articles by Korro Bio, Inc.

Aug-27
Korro to Participate in Upcoming Investor Conferences KRRO GlobeNewswire
Aug-14
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) KRRO GlobeNewswire
Aug-06
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update KRRO +5.39% GlobeNewswire
Jul-10
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) KRRO KRRO -7.28% GlobeNewswire
May-27
Korro to Present at the 2026 Jefferies Global Healthcare Conference KRRO +11.60% GlobeNewswire
May-19
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) KRRO -8.22% GlobeNewswire
May-15
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) KRRO -8.12% GlobeNewswire
May-07
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update KRRO GlobeNewswire
May-05
Korro to Participate in Upcoming Investor Conferences KRRO KRRO +5.96% GlobeNewswire
Apr-16
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences KRRO GlobeNewswire
Apr-10
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) KRRO KRRO +7.97% GlobeNewswire
Mar-12
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update KRRO KRRO +11.30% GlobeNewswire
Mar-09
Korro Announces Oversubscribed $85 Million Private Placement KRRO +10.02% GlobeNewswire
Feb-25
Korro to Present at the TD Cowen 46th Annual Health Care Conference KRRO GlobeNewswire
Jan-20
Korro to Host Virtual Analyst Day on January 27, 2026 KRRO GlobeNewswire
Jan-08
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference KRRO +7.77% GlobeNewswire
Nov-12
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs KRRO KRRO -79.31% GlobeNewswire
Sep-02
Korro to Participate in Upcoming Investor and Scientific Conferences KRRO KRRO +17.25% GlobeNewswire
Aug-12
Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates KRRO +6.25% GlobeNewswire
Jul-21
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 KRRO GlobeNewswire
May-14
Korro to Participate in Upcoming Investor Conferences KRRO -9.26% GlobeNewswire
May-07
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates KRRO -5.85% KRRO +10.55% GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)